H
Helen Lloyd
Researcher at University of Plymouth
Publications - 74
Citations - 2443
Helen Lloyd is an academic researcher from University of Plymouth. The author has contributed to research in topics: Health care & Randomized controlled trial. The author has an hindex of 16, co-authored 67 publications receiving 2142 citations. Previous affiliations of Helen Lloyd include National Health Service & Imperial College London.
Papers
More filters
Journal ArticleDOI
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
Peter B. Jones,Thomas R. E. Barnes,Linda Davies,Graham Dunn,Helen Lloyd,Karen P. Hayhurst,Robin M. Murray,A. Markwick,Shôn Lewis +8 more
TL;DR: In people with schizophrenia whose medication is changed for clinical reasons, there is no disadvantage across 1 year in terms of quality of life, symptoms, or associated costs of care in using FGAs rather than nonclozapine SGAs.
Journal ArticleDOI
Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia
Shôn Lewis,Thomas R. E. Barnes,Linda Davies,Robin M. Murray,Graham Dunn,Karen P. Hayhurst,A. Markwick,Helen Lloyd,Peter B. Jones +8 more
TL;DR: In people with schizophrenia with poor treatment response to 2 or more antipsychotic drugs, there is an advantage to commencing clozapine rather than other SGA drugs in terms of symptom improvement over 1 year.
Journal ArticleDOI
Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.
Linda Davies,Shôn Lewis,Peter B. Jones,Thomas R. E. Barnes,Fiona Gaughran,Karen P. Hayhurst,A. Markwick,Helen Lloyd +7 more
TL;DR: Conventional antipsychotics may be cost-saving and associated with a gain in QALYs compared with atypical antipsychotic drugs, according to the primary and sensitivity analyses.
Journal ArticleDOI
First session solution-focused brief therapy with families who have a child with severe intellectual disabilities: mothers' experiences and views
Helen Lloyd,Rudi Dallos +1 more
TL;DR: In this article, a therapist interviewed the participants, all mothers, two weeks after their initial session, to shed light on the experience of first session solution-focused brief therapy (SFBT) for families who have a child with intellectual disabilities.
Journal ArticleDOI
Case-referent survey of young adults with mesothelioma : I. Lung fibre analyses
J C McDonald,Ben Armstrong,C. W. Edwards,A. R. Gibbs,Helen Lloyd,F. D. Pooley,D. J. Ross,R. M. Rudd +7 more
TL;DR: The steep linear trend in odds ratio shown by amphiboles combined indicates that their effects may be additive, with increased risk from the lowest detectable fibre level, as well as indicating that non-asbestos mineral fibres probably made no contribution to this disease.